Research status: Primary-source verified through FY2026 results on 27 August 2026. Current market reference: $44.68 close on 4 September 2026.
FY2026 results materially strengthened the demand and funding evidence while confirming that IREN remains a capital-structure-sensitive execution story. Management reported $4B of contracted ARR for 2026 capacity, with $1B of ARR operating today as of 26 August. The 2026 capacity is described as largely sold out, including successful delivery of Horizon 1 to Microsoft, and the customer base has broadened to hyperscalers, enterprises, AI developers and frontier labs.
The financing picture also improved: IREN disclosed approximately $14B of existing cash, committed GPU financing and customer prepayments, including $2.8B of GPU financings funding about 90% of associated GPU capex. This reduces the immediate common-equity-funding concern relative to the prior dossier, but does not eliminate it. ARR remains a non-GAAP operating metric and recognized revenue still depends on commissioning, testing, customer acceptance, utilization and contract terms.
At $44.68, the stock still offers substantial upside if contracted capacity converts on schedule and funding remains mostly non-dilutive, but the dispersion remains wide. Current conclusion: keep IREN at investigate/watch. The earnings gate improved the thesis but does not justify a buy plan without a fully reconciled per-share model for financing, dilution, depreciation/replacement capex and project returns.